Company Data
Cingulate Inc.
Ticker
CING
Current Price
$5.61 3.13%
Market Cap
$41.8M
Price Target
Refer to Report
Volume
204.9K
52wk Range
$3.2 - $6.01
Overview
Cingulate Inc is a clinical stage biopharmaceutical company utilizing its proprietary precision timed release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes.